Address : 951 Gateway Boulevard, South San Francisco, California 94080, United States
Phone Number : +1 650-238-9600
Industries : Investment Management
Website : thrxinc.com
Company Description
Theravance, Inc is now called Innoviva.Innoviva is focused on bringing compelling new medicines to patients in areas of unmet need by leveraging its significant expertise in the development, commercialization and financial management of bio-pharmaceuticals. Innoviva's portfolio is anchored by the respiratory assets partnered with Glaxo Group Limited (GSK), including RELVAR®/BREO® ELLIPTA® and ANORO® ELLIPTA®, which were jointly developed by Innoviva and GSK. Under the agreement with GSK, Innoviva is eligible to receive associated royalty revenues from RELVAR®/BREO® ELLIPTA®, ANORO® ELLIPTA® and, if approved and commercialized, VI monotherapy, as well. In addition, Innoviva retains a 15 percent economic interest in future payments made by GSK for earlier-stage programs partnered with Theravance BioPharma, Inc. For more information, please visit Innoviva's website at www.inva.com.
Specialities
- Investment Management
- Financial Services
Financial
Employees Total : 13
Revenue (Yearly) : 264.0M
Total Funding : 98.4M
Latest Funding : 98.4M
Public Company : Yes
Trade Symbol : THRX
Trade Exchange : Nasdaq
Miscellaneous
Load Balancers : Apache
Customer Relationship Management : SAP
Last Updated : 2023-07-06
You Might Be Interested With:
 | Third Watch Protection Services Inc Hamilton, Ontario, Canada Security & Investigations |
 | Taps Uganda Limited Kampala, Central Region, Uganda Transportation/trucking/railroad |
 | Third Order Franciscans of Mary Immaculate Religious Institutions |
 | Tasco France SARL Dourdan, Île-de-France, France Printing |
 | tbk London, England, United Kingdom Marketing & Advertising |
 | Textbizi Investments Harare, Harare Province, Zimbabwe Telecommunications |